Few total artificial hearts make it to human clinical trials, and only the SynCardia Total Artificial Heart has met the rigorous requirements for commercial approval.Continue reading→

The University of Arizona BIO5 Institute hosted the 18th annual KEYS Research Showcase, celebrating the culmination of the KEYS Research Internship for 59 students from 31 Arizona high schools.Continue reading→

“Our center experts and programs help get safe and effective technologies to patients and health care professionals on a daily basis and continue to assure devices are safe and effective once on the market,” says Dr. Shuren. “Rapid technological advances enable us to approve innovations that make a difference in people’s lives. I could not be more proud of my fellow colleagues at CDRH, the family we have built, and what we have accomplished together on behalf of the American public.” (Source)Continue reading→

The Flinn Foundation Seed Grants to Promote Translational Research Program awardees each receive a $100,000 grant over 18 months, plus programmatic benefits. At the end of the grant period, up to two of the most successful projects may receive up to an additional $100,000 over the following year.Continue reading→

 Lloyd’s, the world’s leading insurance market, has granted approval to MCI Syndicate 1966 to offer insurance for clinical trials, facilitated by GATC’s MAT AI platform, to greatly reduce the financial risk in therapeutic drug development.Continue reading→

A decades-long study at the University of Arizona Health Sciences Asthma and Airway Disease Research Center is improving lung health through research.Continue reading→

PHOENIX — Current screening protocols fail to catch a notable number of people carrying genetic mutations associated with hereditary breast and ovarian cancer syndrome and Lynch syndrome, which increase the risk of developing certain cancers. This issue is particularly pronounced among underrepresented minorities. Continue reading→

Phoenix based Flambeau Medical , a full-service contract manufacturing organization serving the medical device and life sciences industries, has added a new industrial 3D printer to expand its rapid prototyping services.Continue reading→

Arizona’s health innovation community generated $38.54 billion in economic impact in 2021 and has set a goal double that impact by 2033.  AZAdvances with its focus on workforce development and  supporting the growth of Arizona life science companies is a key component of this growth strategy. Continue reading→

The Phoenix Bioscience Core (PBC) Team is expanding! With the invaluable support of key stakeholders, we are launching two new initiatives: An Accelerator Program and Workforce Development initiative. Increasing our healthcare workforce and catering to life science startups and Venture Capital are fundamental economic development tools that enhance Arizona’s economy. These initiatives mark a significant step forward in our commitment to fostering growth and innovation within our community.Continue reading→